欧洲电生理学市场：分析与预测（2024-2034）

预计欧洲电生理学市场规模将从 2024 年的 24.9 亿美元成长到 2034 年的 76.4 亿美元，2024-2034 年预测期间的复合年增长率为 11.85%。

心血管疾病（尤其是心律不整）盛行率的上升，以及 3D心臟定位、心导管电气烧灼术平台和先进诊断系统等新技术的快速发展，正在推动欧洲电生理设备市场的发展。人口老化导致心臟病的风险更高，对微创手术的需求也日益增长。由于导管消融手术风险低、恢復快，因此更受青睐。公众对心臟健康的认识不断提高、欧洲医疗保健系统的不断改善以及公共和商业实体的重点投资都是推动市场快速扩张的因素之一。

市场介绍

心律不整（尤其是心房颤动）的盛行率不断上升，以及对微创心血管手术的需求不断增长，推动着欧洲电生理 (EP) 产业的发展。随着欧洲人口老化导致心律不整盛行率增加，早期诊断和有效治疗在临床和经济上变得越来越重要。 3D心臟定位系统、射频导管、冷冻消融导管和人工智慧导航平台等先进技术正在彻底改变电生理学家识别、定位和治疗心臟异常电活动的方式。

欧洲医疗保健系统，尤其是西方和北欧地区，正在投资结合影像处理、映射和机器人导管控制的数位技术以及最先进的 EP 实验室和混合手术室。优惠的报销条件鼓励医院改善基础设施并增加服务项目，尤其是心房颤动消融治疗。同时，对穿戴式心臟监测和门诊手术的需求正在改变病患照护模式。

但仍存在困难。儘管如此，设备成本上升、合格电生理学家短缺以及欧盟各国医疗报销差异阻碍了广泛采用。由于遵守欧盟医疗设备法规，製造商面临额外的复杂性。然而，由于强劲的临床需求和技术创新步伐，欧洲 EP 产业已准备好实现持续成长。

欧洲电生理学市场的趋势、驱动因素与挑战

趋势

• 采用高解析度3D和超高密度心臟定位系统
• 整合人工智慧和机器学习，实现心律不整基材物的自动识别
• 远端和机器人导管导航平台的成长
• EP 成像复合物的出现（MRI/CT 和映射的迭加）
• 扩展穿戴式和植入式监测设备，用于连续心律监测

驱动程式

• 欧洲老化社会中心心房颤动和其他心律不整的盛行率不断上升
• 强而有力的临床证据支持微创心导管电气烧灼术手术
• 西欧各地针对高级 EP 干预措施的报销支持
• 透过设备製造商、医院和研究机构之间的合作促进技术创新
• 病人和医生对更安全、更有效的心律不整治疗的需求日益增加

任务

• 最先进的 EP 实验室和设备的资本和维护成本高昂
• 欧盟成员国报销框架分散，医院预算波动
• 需要专门培训，缺乏经验丰富的电生理学家
• 新的环保技术监管复杂且核准流程漫长
• 传统医院 IT 系统与新 EP 平台之间的资料整合和互通性障碍

成长/行销策略：伙伴关係、联盟和业务扩展占 2022 年 1 月至 2024 年 12 月欧洲电生理学市场关键发展的最大数量。

竞争策略：欧洲电生理学市场有大量现有参与者及其产品和服务组合。本研究分析和描述的欧洲电生理学市场的主要企业包括提供电生理学产品和服务的现有公司。

主要市场参与企业及竞争格局

所介绍的公司是根据从顶尖专家收集的意见以及对公司覆盖范围、产品系列和市场渗透率的分析而选出的。

本报告研究了欧洲电生理学市场，提供了市场概况以及各国趋势和参与市场的公司概况。

目录

执行摘要

第一章市场：产业展望

• 产业展望
  • 供应链概览
  • 赎回方案
  • 价值链分析
• 趋势：现况与未来影响评估
  • 先进 3D 地图系统和即时成像技术的采用率不断提高
  • 人工智慧在预测模型和个人化医疗的新兴应用
• 专利分析
  • 专利申请趋势（按国家和年份）
• 法律规范
  • 欧洲联盟
  • 英国
  • 法国
  • 德国
  • 义大利
  • 西班牙
• 市场动态概览
  • 市场驱动因素
  • 市场限制
  • 市场机会

2. 电生理学市场（按地区划分），百万美元，2022-2034 年

• 区域摘要
• 欧洲
  • 区域概况
  • 市场成长动力
  • 成长抑制因素
  • 法国
  • 义大利
  • 德国
  • 英国
  • 西班牙
  • 其他的

第三章 市场竞争基准化分析与公司概况

• 电生理学市场：竞争格局
  • 企业策略 2019 年 1 月 - 2024 年 12 月
  • 策略性倡议（按财年），2019 年 1 月至 2024 年 12 月
  • 伙伴关係、联盟和业务扩展
  • 新服务
  • 监管部门核准
  • 资金筹措活动
  • 合併与收购
  • 2015 年至 2023 年的关键发展与里程碑
• 公司简介
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Volta Medical
  • CathVision ApS
  • Biotronik

第四章调查方法

Introduction to Europe Electrophysiology Market

The Europe electrophysiology market is projected to reach $7.64 billion by 2034 from $2.49 billion in 2024, growing at a CAGR of 11.85% during the forecast period 2024-2034. The rising prevalence of cardiovascular disorders, particularly arrhythmias, and the quick development of new technologies such as 3D cardiac mapping, catheter ablation platforms, and sophisticated diagnostic systems are driving the market for electrophysiology devices in Europe. The need for minimally invasive procedures is increasing due to an ageing population at higher risk of heart diseases; catheter-based ablations are preferred because of their lowered procedural risks and quicker recovery. Increased public awareness of heart health, ongoing improvements to the European healthcare system, and focused investments from public and commercial entities are all contributing to the market's rapid expansion.

Market Introduction

The growing incidence of arrhythmias, especially atrial fibrillation, and the growing need for minimally invasive cardiac procedures are driving the electrophysiology (EP) industry in Europe. Due to the increased prevalence of heart rhythm abnormalities brought on by Europe's ageing population, early diagnosis and efficient treatment are becoming more and more important from a clinical and financial standpoint. The way electrophysiologists identify, locate, and treat aberrant electrical activity in the heart is being revolutionised by advanced technology like 3D cardiac mapping systems, radiofrequency and cryoablation catheters, and AI-enabled navigation platforms.

Digital technologies that combine imaging, mapping, and robotic catheter control, as well as contemporary EP labs and hybrid operating suites, are being invested in by European healthcare systems, particularly those in the Western and Nordic areas. Favourable reimbursement conditions are pushing hospitals to improve infrastructure and increase service offerings, especially for atrial fibrillation ablation. In the meantime, patient care paradigms are changing due to the desire for wearable cardiac monitoring and outpatient operations.

But there are still difficulties. Adoption is nevertheless hampered by high equipment prices, a shortage of qualified electrophysiologists, and disparities in reimbursement between EU nations. Manufacturers are further complicated by regulatory compliance under the EU Medical Device Regulation. Nonetheless, Europe's EP industry is well-positioned for sustained growth due to robust clinical need and innovation pace.

Market Segmentation:

Segmentation 1: by Region

• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe

Europe Electrophysiology Market Trends, Drivers and Challenges

Trends

• Adoption of high-resolution 3D and ultra-high-density cardiac mapping systems
• Integration of AI and machine learning for automated arrhythmia substrate identification
• Growth of remote and robotic catheter navigation platforms
• Emergence of combined EP-imaging suites (MRI/CT overlay with mapping)
• Expansion of wearable and implantable monitoring devices for continuous rhythm surveillance

Drivers

• Increasing prevalence of atrial fibrillation and other arrhythmias in Europe's aging population
• Strong clinical evidence favoring minimally invasive catheter-ablation procedures
• Reimbursement support across Western Europe for advanced EP interventions
• Collaboration between device makers, hospitals and research institutes accelerating innovation
• Heightened patient and physician demand for safer, more effective heart-rhythm therapies

Challenges

• High capital and maintenance costs for state-of-the-art EP labs and equipment
• Fragmented reimbursement frameworks and variable hospital budgets across EU member states
• Need for specialized training and scarcity of experienced electrophysiologists
• Regulatory complexity and lengthy approval pathways for novel EP technologies
• Data-integration and interoperability hurdles between legacy hospital IT systems and new EP platforms

How can this report add value to an organization?

Growth/Marketing Strategy: The partnership, alliance, and business expansion accounted for the maximum number of key developments in the Europe electrophysiology market between January 2022 and December 2024.

Competitive Strategy: The Europe electrophysiology market has numerous established players with product and service portfolios. Key players in the Europe electrophysiology market analyzed and profiled in the study involve established players offering electrophysiology products and services.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the Europe electrophysiology market include:

• Siemens Healthineers AG
• Biotronik
• Koninklijke Philips N.V.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

• 1.1 Industry Outlook
  • 1.1.1 Supply Chain Overview
    • 1.1.1.1 Risks within the Supply Chain
  • 1.1.2 Reimbursement Scenario
    • 1.1.2.1 Overview
    • 1.1.2.2 Europe
  • 1.1.3 Value Chain Analysis
    • 1.1.3.1 Overview
    • 1.1.3.2 Stakeholders at Each Stage of the Value Chain
    • 1.1.3.3 Strategic Partnerships, Mergers, and Acquisitions in the Value Chain
• 1.2 Trends: Current and Future Impact Assessment
  • 1.2.1 Increasing Adoption of Advanced 3D Mapping Systems and Real-Time Imaging
  • 1.2.2 Emerging Use of Artificial Intelligence in Predictive Modelling and Personalized Treatment
• 1.3 Patent Analysis
  • 1.3.1 Patent Filing Trend (by Country, Year)
• 1.4 Regulatory Framework
  • 1.4.1 European Union (EU)
  • 1.4.2 U.K.
  • 1.4.3 France
  • 1.4.4 Germany
  • 1.4.5 Italy
  • 1.4.6 Spain
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Innovative Technological Developments
    • 1.5.1.2 Proliferation of New Entrants and Its Market Implications
    • 1.5.1.3 Expanding Investments, Funding, and Grant Support for Cardiac Surgery and Electrophysiology
    • 1.5.1.4 Increasing Disease Incidence and Procedural Volume
  • 1.5.2 Market Restraints
    • 1.5.2.1 High Product Costs and Inadequate Reimbursement Policies
    • 1.5.2.2 Increasing Device Reuse and Reprocessing Trends
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Expansion of Emerging Markets
    • 1.5.3.2 Next-Generation Ablation Technologies

2 Electrophysiology Market (by Region), $Million, 2022-2034

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 France
  • 2.2.5 Italy
  • 2.2.6 Germany
  • 2.2.7 U.K.
  • 2.2.8 Spain
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Electrophysiology Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2019-December 2024
  • 3.1.2 Strategic Initiatives (by Year), January 2019-December 2024
  • 3.1.3 Partnerships, Alliances, and Business Expansions
  • 3.1.4 New Offerings
  • 3.1.5 Regulatory Approval
  • 3.1.6 Funding Activities
  • 3.1.7 Merger and Acquisition
  • 3.1.8 Key Developments and Milestones, 2015-2023
• 3.2 Company Profiles
  • 3.2.1 Koninklijke Philips N.V.
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers
    • 3.2.1.5 Analyst View
  • 3.2.2 Siemens Healthineers AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers
    • 3.2.2.5 Analyst View
  • 3.2.3 Volta Medical
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers
    • 3.2.3.5 Analyst View
  • 3.2.4 CathVision ApS
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers
    • 3.2.4.5 Analyst View
  • 3.2.5 Biotronik
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products
    • 3.2.5.3 Top Competitors
    • 3.2.5.4 Target Customers
    • 3.2.5.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Key Events to Keep Track of within the Electrophysiology Market
• Figure 2: Supply Chain and Risks within the Supply Chain
• Figure 3: Electrophysiology Market, Patent Analysis (by Country), January 2021-December 2024
• Figure 4: Electrophysiology Market, Patent Analysis (by Year), January 2021-December 2024
• Figure 5: Europe Electrophysiology Market, $Billion, 2022-2034
• Figure 6: France Electrophysiology Market, $Billion, 2022-2034
• Figure 7: Italy Electrophysiology Market, $Billion, 2022-2034
• Figure 8: Germany Electrophysiology Market, $Billion, 2022-2034
• Figure 9: U.K. Electrophysiology Market, $Billion, 2022-2034
• Figure 10: Spain Electrophysiology Market, $Billion, 2022-2034
• Figure 11: Rest-of-Europe Electrophysiology Market, $Billion, 2022-2034
• Figure 12: Corporate Strategies, January 2019-December 2024
• Figure 13: Share of Strategic Initiatives, January 2019-December 2024
• Figure 14: Strategic Initiatives (by Year), January 2019-December 2024
• Figure 15: Partnerships, Alliances, and Business Expansions, January 2019-December 2024
• Figure 16: New Offerings, January 2019-December 2024
• Figure 17: Regulatory Approval, January 2019-December 2024
• Figure 18: Funding Activities, January 2019-December 2024
• Figure 19: Merger And Acquisition, January 2019-December 2024
• Figure 20: Data Triangulation
• Figure 21: Top-Down and Bottom-Up Approach
• Figure 22: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Electrophysiology Market Trend Analysis
• Table 3: Impact Analysis of Market Navigating Factors, 2024-2034
• Table 4: Electrophysiology Market (by Region), $Billion, 2022-2034